Teratogenicity of Gabapentin in Mice
Journal Title: Journal of Medical Science And clinical Research - Year 2014, Vol 2, Issue 12
Abstract
Introduction: Present work aims to study and elucidate the safety profile of the antiepileptic doses of gabapentin during pregnancy, and to evaluate if any gabapentin induced murine fetotoxicity at different dose levels. Methods: A total of 60 pregnant mice divided into a total of 12 groups, of 5 mice each were exposed to gabapentin in 4 different doses of 0 (control), or 113, 226, or 452 mg/kg body weight per day, at 3 different gestational stages including early gestation (1-6 day), mid gestation (7-12 day), and late gestation (13-17 day). The pregnant mice were euthanatized on day 18 of gestation, and foetuses were examined for teratogenic manifestations. Brains were dissected out and examined for gross changes, malformations, histological changes, and quantitative protein estimation. Results: Foetal resorptions were observed in all treated groups with gabapentin administration at early gestation (1-6 day), and mid gestation (7-12 day); on the other hand, growth retardation along with stunting in size of live foetuses were observed in all the mid gestation (7-12 day), and late gestation (13-17 day) treated groups. Various gross malformations were observed with all the three doses (113, 226, and 452 mg/kg body weight per day) when with gabapentin was administered at mid gestation (7-12 day). Same trends were confirmed by gross and microscopic examination of brains along with quantitative protein estimation. Conclusion: Gabapentin should not be prescribed in pregnancy, as no therapeutic dose of gabapentin is safe during pregnancy as far as the foetal risk is concerned
Authors and Affiliations
Dr Md. Abu Nasar
Keywords
Related Articles
- EP ID EP208089
- DOI -
- Views 102
- Downloads 0
A Rare Case of Breast Tuberculosis
Pulmonary tuberculosis is one of the most widespread and persistent human infections in the world. Breast tuberculosisis an uncommon disease, with an incidence of less than 0.1% of all breast lesions in Western countries...
Effectiveness of Misoprostol for the Prevention of Postpartum Haemorrhage: A Review
Postpartum haemorrhage (PPH) is the major cause of maternal morbidity and mortality globally. Prevention of PPH will reduce the number of maternal deaths in rural communities of developing countries. This study aim to ac...
Uptake of skilled birth deliveries in women of reproductive age: Results of a cross-sectional survey following implementation of free maternal services in Nyatike Sub-County, Kenya
Background: As is the trend globally, in Kenya, maternal mortality ratio remains high at 546/100,000 and 362/100,000 live births, respectively. Approximately 830 women die from pregnancy- or childbirth-related complicati...
A Pharmacoepidemiological Study Of Ticagrelor & Current Antiplatelet Agents In Acute Coronary Syndrome (ACS) & Percutaneous Transluminal Coronary Angioplasty (PTCA)
The incidence of ACS is rapidly increasing in India & causing high mortality. In the treatment pattern of ACS & PTCA, antiplatelet agents are prescribed as a part of maintenance & prophylactic therapy. Ticagrelor, a newe...
Mean Platelet Volume as an Independent Risk Factor for Acute Myocardial Infarction and Its Short Term Prognostic Significance
Background of study: The biological events that occur in the Coronary system immediately preceding acute coronary syndromes are still unclear. However platelets are definitely involved, and changes in platelet structure...